scholarly article | Q13442814 |
P356 | DOI | 10.1034/J.1600-0609.2002.02772.X |
P698 | PubMed publication ID | 12431240 |
P50 | author | Hanneke C Kluin-Nelemans | Q50757186 |
P2093 | author name string | B Löwenberg | |
R Willemze | |||
P Sonneveld | |||
P C Huijgens | |||
L F Verdonck | |||
L M Faber | |||
C A Uyl-de Groot | |||
M van Agthoven | |||
P2860 | cites work | A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project | Q28251216 |
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma | Q28297805 | ||
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma | Q28316407 | ||
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP | Q28346778 | ||
Treatment of non-Hodgkin's lymphoma | Q40885119 | ||
Survival of patients with cancer | Q42114148 | ||
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study | Q43514960 | ||
Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project | Q50134451 | ||
Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. | Q50994497 | ||
Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a pros | Q53474552 | ||
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial. | Q53537168 | ||
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group | Q71617622 | ||
National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project | Q71859454 | ||
CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial.(PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of Hemato | Q72997742 | ||
Impact of clinical trials on the cost of cancer care | Q73821541 | ||
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study | Q74082921 | ||
Extrapolation of cost-effectiveness information to local settings | Q77165307 | ||
Critical reviews of economic analyses in order to make health care decisions for cancer | Q77713867 | ||
Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands | Q77713990 | ||
P433 | issue | 4 | |
P921 | main subject | chemotherapy | Q974135 |
P304 | page(s) | 213-220 | |
P577 | publication date | 2002-10-01 | |
P1433 | published in | European Journal of Haematology | Q15765799 |
P1476 | title | Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma | |
P478 | volume | 69 |
Q45252389 | Cost-effectiveness of rituximab (MabThera) in diffuse large B-cell lymphoma in The Netherlands |
Q37609370 | Costs of multiple myeloma and associated skeletal-related events in The Netherlands |
Q73035188 | Costs of prostate cancer, metastatic to the bone, in the Netherlands |
Q35967345 | Economic assessment in the management of non-Hodgkin's lymphoma |
Q73560905 | Recent publications in hematological oncology |
Search more.